Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2018-11-14 Interim / Quarterly Rep…
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a formal communication from Ajooni Biotech Limited to the National Stock Exchange of India, dated November 14, 2018. It references the approval and recording of unaudited financial results for the half year ended September 30, 2018, along with a Limited Review Report from the statutory auditor. The document also includes management decisions such as the resignation and appointment of the Chief Financial Officer. The presence of unaudited financial results and a limited review report for a half-year period indicates this is an Interim / Quarterly Report. The document contains substantive financial data and analysis, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2018-11-14 English
Board Meeting — Other business matters
Board/Management Information Classification · 95% confidence The document is a short letter dated November 10, 2018, addressed to the National Stock Exchange of India. It announces additions to the agenda for a board meeting scheduled on November 14, 2018, specifically the resignation of the CFO and appointment of a new CFO. The content focuses on management changes and is not a full report or financial statement. The document length is only 1211 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it fits the category of Board/Management Information (MANG).
2018-11-10 English
Board Meeting — Financial Results
Regulatory Filings
2018-11-05 English
Shareholders meeting
Regulatory Filings Classification · 100% confidence The document contains only a placeholder for a picture and has a very short length (54 characters). There is no textual content, no financial data, no announcements, or any other information to classify it as a specific report or filing. Given the lack of content, the document does not fit any specific category and defaults to Regulatory Filings (RNS) as a fallback category for miscellaneous filings without substantive content.
2018-10-30 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Consolidated Scrutinizer Report for E-Voting and Poll conducted at the Annual General Meeting (AGM) of Ajooni Biotech Limited held on September 28, 2018. It details the voting results on various agenda items including adoption of financial statements, appointment of directors, appointment of auditors, and issuance of convertible warrants. The report is prepared by a company secretary acting as scrutinizer and includes vote counts from remote e-voting and polling at the AGM. This type of document is an official report of voting results from a shareholder meeting, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not the AGM presentation itself, nor is it the full annual report or financial statements, but specifically the voting results report. The length and detail confirm it is not a mere announcement or certification but a full scrutinizer report. Therefore, the correct classification is DVA with high confidence.
2018-10-30 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings
2018-10-23 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.